Female Reproductive System Endometrioid Adenocarcinoma

Female Reproductive System Endometrioid Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

111 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 20
Ph III recruiting: 6
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02364713	MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer	terminated	Phase 2	17	Mayo ClinicOTHER	1	Dec 11, 2025	clinicaltrials
NCT02923739	Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	terminated	Phase 2	9	M.D. Anderson Cancer CenterOTHER	1	Mar 13, 2024	clinicaltrials